## ROL: Rollins, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_20 -1.2% below STRENGTH zone (4.0-10.0%); PEG 3.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($57.01)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 3
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Rollins To Host 2024 Investor and Analyst Conference on May 17th**
- Source: GuruFocus | 20260102T180836 | Somewhat-Bullish | Relevance: 100%
- Rollins, Inc. (NYSE: ROL) announced it will host its 2024 Investor and Analyst Conference on Friday, May 17, at 9 a.m. Eastern Time. CEO Jerry Gahlhoff, CFO Ken Krause, and other leadership team members will present on the Company's strategic priorities. A live webcast and archived replay will be available on the Rollins website.

**2. 1 Safe-and-Steady Stock to Target This Week and 2 We Ignore**
- Source: Finviz | 20260101T234000 | Bullish | Relevance: 97%
- This article identifies one low-volatility stock, Rollins (ROL), as a potential buy due to its strong revenue growth, high gross margins, and robust free cash flow. Conversely, it advises caution on Champion Homes (SKY) and UL Solutions (ULS) due to slowing sales, diminishing returns, and unexciting growth trends. The piece emphasizes the importance of choosing dynamic companies for portfolio growth.

**3. Short Interest in Rentokil Initial PLC (NYSE:RTO) Expands By 25.2%**
- Source: MarketBeat | 20260101T090929 | Somewhat-Bullish | Relevance: 63%
- Short interest in Rentokil Initial PLC (NYSE:RTO) increased by 25.2% to 3,882,315 shares as of December 15th, representing a short-interest ratio of 5.9 days. Analyst sentiment for the company is generally positive, with a "Moderate Buy" consensus and an average price target of $34.00. Shares recently traded near their 1-year high, while institutional ownership remains relatively low at 9.91%.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-17 | Morgan Stanley | $72 | $58 | +24% |
| 2025-12-05 | Barclays | $72 | $60 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-17 | Morgan Stanley | up | Overweight |
| 2025-12-05 | Barclays | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 7 ($3296.08M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 7.6% (+4.2%)
- Blackrock Inc.: 6.0% (+1.2%)
- State Street Corpora: 2.5% (+1.4%)
- Kayne Anderson Rudni: 2.0% (-2.8%)
- Geode Capital Manage: 2.0% (+1.7%)

### Key Risks

1. Heavy insider selling: $3296M sold (7 transactions in 90 days).
2. Valuation stretched: PEG 4.0x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.96 signals overvaluation risk, limited margin of safety. Forward P/E 46.1x stretched relative to 12% growth. Quality metrics strong (ROE 36%, ROA 15%). Analyst sentiment positive (2 raises, avg +22%). Insider selling cluster ($3296.1M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $28.4B |
| Beta | 0.79 |
| 52W Range | $45.34 - $61.84 |
| Short Interest | 3.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.96 |
| Forward P/E | 46.1 |
| Current P/E | 51.7 |
| YoY Growth | 12.1% |
| EPS Direction | STABLE |

### Technicals

MRS_20 weakening modestly (-0.8% over 5 days). Below STRENGTH zone by 5.2pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). RSI neutral at 43. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.25% (CS: 25) | Neutral |
| RSI_14 | 42.9 | Neutral |
| MACD Histogram | -0.15 | Bearish |
| vs SMA20 | 0.982x | Below |
| vs SMA50 | 0.996x | Below |
| vs SMA200 | 1.034x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $59.01
- **Stop Loss:** $57.01 (3.4% risk)
- **Target:** $61.01 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 300
- **Position Value:** $17,703.00
- **Portfolio %:** 17.70%
- **Risk Dollars:** $600.00
- **Risk Per Trade:** 0.60%
- **Modifiers:** L1 120% | L2 50% | Combined 0.60x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-02-18 (Est: $0.27)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +6.3% |
| 2025Q2 | $0.30 | $0.30 | -0.7% |
| 2025Q1 | $0.22 | $0.22 | +1.3% |
| 2024Q4 | $0.23 | $0.23 | -0.8% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*